Clinical Trials Arena June 12, 2024
GlobalData

Spectrum’s automatic integration of ongoing financial forecasting removes the need for manual input in modelling budgets.

US-based clinical trial software company Lokavant has launched Spectrum, a feasibility software solution designed to optimise studies.

The AI-powered offering is designed to enhance trials at all stages, from strategic planning to mid-study re-forecasting.

Spectrum aims to assist study teams in forecasting, streamlining and controlling trial timelines and expenditures on a real-time basis, allowing iterative feasibility assessments and adjustments to be carried out in mid-study.

The solution is also intended to enable more precise strategic and operational feasibility analyses at the start of a trial, as well as during mid-study evaluations.

In addition, Spectrum’s automatic integration of ongoing financial forecasting removes the need for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Clinical Trials, Technology, Trends
AI tool helps find life-saving medicine for rare disease
Report: AI controls growing VC attention in Europe
Affineon Health Raises $5M for AI-Powered Physician Inbox Management
Will biased AI ruin everything?
Sam Altman’s Fusion Power Startup Is Eyeing Trump’s $500 Billion AI Play

Share This Article